China Next Generation Cancer Diagnostics Market (2025-2031) | Analysis, Outlook, Share, Segmentation, Companies, Trends, Forecast, Growth, Size & Revenue, Competitive Landscape, Value, Industry

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 China Country Macro Economic Indicators

3.2 China Next Generation Cancer Diagnostics Market Revenues & Volume, 2021 & 2031F

3.3 China Next Generation Cancer Diagnostics Market - Industry Life Cycle

3.4 China Next Generation Cancer Diagnostics Market - Porter's Five Forces

3.5 China Next Generation Cancer Diagnostics Market Revenues & Volume Share, By Technology, 2021 & 2031F

3.6 China Next Generation Cancer Diagnostics Market Revenues & Volume Share, By Application, 2021 & 2031F

3.7 China Next Generation Cancer Diagnostics Market Revenues & Volume Share, By Cancer, 2021 & 2031F

3.8 China Next Generation Cancer Diagnostics Market Revenues & Volume Share, By Function, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of cancer in China

4.2.2 Rising healthcare expenditure in the country

4.2.3 Government initiatives to improve cancer diagnosis and treatment

4.2.4 Technological advancements in cancer diagnostics

4.2.5 Growing awareness about early cancer detection

4.3 Market Restraints

4.3.1 Limited access to advanced diagnostic technologies in remote areas

4.3.2 High cost associated with next-generation cancer diagnostics

4.3.3 Stringent regulatory requirements for product approval

4.3.4 Lack of skilled healthcare professionals for interpreting diagnostic results

6.1 China Next Generation Cancer Diagnostics Market, By Technology

6.1.1 Overview and Analysis

6.1.2 China Next Generation Cancer Diagnostics Market Revenues & Volume, By Technology, 2021- 2031F

6.1.3 China Next Generation Cancer Diagnostics Market Revenues & Volume, By Next-generation Sequencing, 2021- 2031F

6.1.4 China Next Generation Cancer Diagnostics Market Revenues & Volume, By qPCR & Multiplexing, 2021- 2031F

6.1.5 China Next Generation Cancer Diagnostics Market Revenues & Volume, By Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR), 2021- 2031F

6.1.6 China Next Generation Cancer Diagnostics Market Revenues & Volume, By Protein Microarrays, 2021- 2031F

6.1.7 China Next Generation Cancer Diagnostics Market Revenues & Volume, By DNA Microarrays, 2021- 2031F

6.2 China Next Generation Cancer Diagnostics Market, By Application

6.2.1 Overview and Analysis

6.2.2 China Next Generation Cancer Diagnostics Market Revenues & Volume, By Biomarker Development, 2021- 2031F

6.2.3 China Next Generation Cancer Diagnostics Market Revenues & Volume, By CTC Analysis, 2021- 2031F

6.2.4 China Next Generation Cancer Diagnostics Market Revenues & Volume, By Proteomic Analysis, 2021- 2031F

6.2.5 China Next Generation Cancer Diagnostics Market Revenues & Volume, By Epigenetic Analysis, 2021- 2031F

6.2.6 China Next Generation Cancer Diagnostics Market Revenues & Volume, By Genetic Analysis, 2021- 2031F

6.3 China Next Generation Cancer Diagnostics Market, By Cancer

6.3.1 Overview and Analysis

6.3.2 China Next Generation Cancer Diagnostics Market Revenues & Volume, By Lung Cancer, 2021- 2031F

6.3.3 China Next Generation Cancer Diagnostics Market Revenues & Volume, By Breast Cancer, 2021- 2031F

6.3.4 China Next Generation Cancer Diagnostics Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F

6.3.5 China Next Generation Cancer Diagnostics Market Revenues & Volume, By Cervical Cancer, 2021- 2031F

6.3.6 China Next Generation Cancer Diagnostics Market Revenues & Volume, By Others, 2021- 2031F

6.4 China Next Generation Cancer Diagnostics Market, By Function

6.4.1 Overview and Analysis

6.4.2 China Next Generation Cancer Diagnostics Market Revenues & Volume, By Therapeutic Monitoring, 2021- 2031F

6.4.3 China Next Generation Cancer Diagnostics Market Revenues & Volume, By Companion Diagnostics, 2021- 2031F

6.4.4 China Next Generation Cancer Diagnostics Market Revenues & Volume, By Prognostics, 2021- 2031F

6.4.5 China Next Generation Cancer Diagnostics Market Revenues & Volume, By Cancer Screening, 2021- 2031F

6.4.6 China Next Generation Cancer Diagnostics Market Revenues & Volume, By Risk Analysis, 2021- 2031F

7.1 China Next Generation Cancer Diagnostics Market Export to Major Countries

7.2 China Next Generation Cancer Diagnostics Market Imports from Major Countries

8.1 Adoption rate of next-generation cancer diagnostic technologies in China

8.2 Number of research and development collaborations for innovative cancer diagnostic solutions

8.3 Patient outcomes and survival rates post-implementation of advanced diagnostic techniques

9.1 China Next Generation Cancer Diagnostics Market Opportunity Assessment, By Technology, 2021 & 2031F

9.2 China Next Generation Cancer Diagnostics Market Opportunity Assessment, By Application, 2021 & 2031F

9.3 China Next Generation Cancer Diagnostics Market Opportunity Assessment, By Cancer, 2021 & 2031F

9.4 China Next Generation Cancer Diagnostics Market Opportunity Assessment, By Function, 2021 & 2031F

10.1 China Next Generation Cancer Diagnostics Market Revenue Share, By Companies, 2024

10.2 China Next Generation Cancer Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters